The French Bulldog: Brachycephalic Risk Stacked High
The French Bulldog carries one of the highest hereditary risk profiles of any popular breed - an estimated lifetime cost of $28,000 over roughly 8-10 years, if one or two major problems hit, which is more common than not. The headline risk is Brachycephalic Obstructive Airway Syndrome (BOAS) at 58.9% on objective airway testing (Liu et al. 2017), with corrective surgery running $2,000-$6,000 and sometimes needing repeat operations.
It doesn't stop there. Our breed profile estimates skin allergies at 20% ($1,000-$4,000 per year of ongoing management), luxating patella at ~7% (5.4x the odds of crossbreds, O'Neill et al. 2016) ($1,500-$3,500 per knee), cherry eye with no breed-specific prevalence published ($500-$2,000 per eye), IVDD at ~20% (Wee & Nin 2025) ($3,000-$8,000 emergency surgery), and hip dysplasia at ~33% (OFA screening) ($1,500-$7,000 per hip). Several of these are chronic, so the Frenchie's cost profile is less one catastrophic bill and more a series of expensive episodes over the dog's life.
What this means for the policy: a Frenchie owner needs a high coverage limit (chronic plus surgical costs add up fast), a strong reimbursement rate given how likely claims are, and above all early enrollment - because allergies, breathing issues, and patella notes tend to appear young, and any of them becomes a permanent pre-existing exclusion once documented.